Some pain, no gain: Experiences with the no-claim rebate in the Dutch health care system

Health Economics, Policy and Law

Volumn 4, Issue 4, 2009, Pages 405-424

  Holland, J ^b,c   Van exel, N J A ^b   Schut, F T ^b   Brouwer, W B F ^a,b  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c KPMG   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CONSULTATION; CONSUMER ATTITUDE; FINANCIAL MANAGEMENT; GENERAL PRACTITIONER; HEALTH CARE COST; HEALTH CARE SYSTEM; HEALTH CARE UTILIZATION; HEALTH ECONOMICS; HEALTH INSURANCE; MATERNAL CARE; MEDICAL CARE; NETHERLANDS; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; DELIVERY OF HEALTH CARE; DIFFUSION OF INNOVATION; FEMALE; HEALTH CARE SURVEYS; HEALTH SERVICES; HEALTH SERVICES MISUSE; HUMANS; INSURANCE CLAIM REPORTING; MALE; MIDDLE AGED; NETHERLANDS; PROGRAM EVALUATION; REIMBURSEMENT MECHANISMS; YOUNG ADULT;

EID: 70350738587     PISSN: 17441331     EISSN: 1744134X     Source Type: Journal    
DOI: 10.1017/S1744133109004861     Document Type: Article

References (24)

1. Baarsma, B., I. deGroot, and L. Kok (2004), 'No-claim prikkelt zorggebruiker minder dan eigen risico', Economenblad, 26 (4/5).
2. Carlsson, F. and P. Martinsson (2003), 'Design techniques for stated preference methods in health economics', Health Economics, 12 281-294.
3. CPB (2004), Het effect van de invoering van eigen betalingen in de ZFW, Den Haag: CPB.
4. Cutler, D.M. (2002), 'Equality, efficiency and marker fundamentals: The dynamics of international medical-care reform',Journal of Economic Literature, 40: 881-906.
5. De Jong, J.D., R.A. Verheij, and P.P. Groenewegen (2006), 'Minder zorggebruik door noclaimteruggaveregeling', Medisch Contact,61 (29/30): 1204-1205.
6. Donaldson, C., R. Thomas, and D.J. Torgerson (1997), 'Validity of open ended and payment scale approaches to eliciting willingness to pay', Applied Economics, 29: 79-84.
7. Goudriaan, R, H. Bartelings, V. Thio, and R.W.D.J Snijders (2006), Evaluatie van de noclaimteruggaveregeling, 's-Gravenhage: APE.
8. Goudriaan, R., R. Lalloesingh, and P. Vemer (2007), 'Eindevaluatie van de no-claimteruggaveregeling: Achtergrondrapport van de tweede fase', Ape rapport nr. 343c, Den Haag
9. Groenewegen, P.P. and J.D. de Jong (2004), 'No-claimteruggaaf in ziekenfondsverzekering', Medisch Contact, 59(24): 981-984.
10. Kahneman, D. and A. Tversky (1979), 'Prospect theory: An analysis of decision making under risk', Econometrica, 47(2): 263-292.
11. Marka, T.L. and J. Swait (2004), 'Using stated preference and revealed preference modeling to evaluate prescribing decisions', Health Economics, 13: 563-573
12. Ministry of Health (2004), Wijziging van de Ziekenfondswet in verband met het invoeren van een no-claimteruggaaf voor verzekerden die geen of weinig gebruik hebben gemaakt van zorg waarop ingevolge die wet aanspraak bestaat, Kamerstuken II 2005-06, 29 483, nr. 3.
13. Ministry of Health (2006a), The new care system in the Netherlands Den Haag: SDU (available via http://www.minvws.nl/en/folders/z/2006/ the-new-health-insurance-systemin-three-languages.asp).
14. Ministry of Health (2006b), Evaluatie no-claimteruggaaf, Kamerstuken II 2005-06, 29 483, nr. 27.
15. Ministry of Health (2006c), Financiële gevolgen no-claim, Den Haag: VWS.
16. Ministry of Health (2007), Wetvoorstel wijziging van de Zorgverzekeringswet en de wet op de zorgtoeslag houdende vervanging van de no-claim teruggave door een verplicht eigen risico, Kamerstuken II 2006-07, 31 094, nrs. 1-2.
17. Schut, F.T. (2004) 'Bezuinigingen en hervormingen in de zorg', ESB 89(4443): 471-475.
18. Schut, F.T. and W.P.M.M. van de Ven (2005), 'Rationing and competition in the Dutch health care system', Health Economics, 14: S59-S74.
19. Vektis (2006), Wat krijgt een verzekerde in 2007 aan no-claim terug Zeist: Vektis.
20. Ven, W.P.M.M. van de and F.T. Schut (2008), 'Universal mandatory health insurance in the Netherlands: A model for the United States?', Health Affairs, 27(3): 771-781.
21. Vliet R van (2004) 'Deductibles and health care expenditures: Empirical estimates of price sensitivity based on administrative data', International Journal of Health Care Finance and Economics, 4: 283-305.
22. Whynes, D.K., E. Frew, and J.L. Wolstenholme (2003), 'A comparison of two methods for eliciting contingent valuations of colorectal cancer screening', Journal of Health Economics, 22: 555-574.
23. Wijlick, E.H.J. and M.E.J de Rond (2006), KNMG-monitor Zorgverzekeringswet, Utrecht: KNMG.
24. Zweifel, P. (1987), 'Bonus systems in health insurance: A microeconomic analysis', Health Policy, 7: 273-288.